Tratamiento del síndrome antifosfolípido
Keywords: 
Antiphospholipid syndrome
Thrombosis
Fetal death
Lupus anticoagulant
Issue Date: 
2007
Publisher: 
Ediciones Universidad de Navarra
ISSN: 
0556-6177
Citation: 
Paramo JA, Garcia R, Rodriguez P, Panizo E, Lecumberri R. Tratamiento del síndrome antifosfolípido. Rev Med Univ Navarra 2007 Oct-Dec;51(4):38-41.
Abstract
The antiphospholipid syndrome (APS) is a disorder of recurrent thrombosis and/or pregnancy loss associated with the presence of antiphospholipid antibodies and persistently positive lupus anticoagulant, anticardiolipin or anti beta2-glycoprotein1. Oral anticoagulants are the best available and most effective treatment for the secondary prevention of recurrent venous or arterial thrombosis. Patients with APS are treated with long-term therapy to prolong the INR to 2.0-3.0. Low-molecular-weight heparin in combination with low-aspirin dose is a reasonable strategy to avoid pregnancy loss in women with this syndrome.

Files in This Item:
File: 
RevMedUnivNavarra2007_5143841.pdf
Description: 
Size: 
28,42 kB
Format: 
Adobe PDF


Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.